Drug Safety Concerns Help Depress U.S. Sales Forecasts From IMS Health
Executive Summary
Drug safety concerns contributed to IMS Health's decision to lower its forecast for the compound annual pharmaceutical sales growth rate over the next several years
You may also be interested in...
Emerging Market Rx Growth Heating Up As Mature Markets Cool, IMS Says
The improving regulatory environment in emerging international markets is helping to drive global pharmaceutical growth despite a slowdown within mature markets
Emerging Market Rx Growth Heating Up As Mature Markets Cool, IMS Says
The improving regulatory environment in emerging international markets is helping to drive global pharmaceutical growth despite a slowdown within mature markets
Plavix, Oncologics Are Top Global Growth Stories Of 2007, IMS Reports
Despite slowing growth, 2007 witnessed the greatest increase in prescription drug sales ever, according to IMS Health data